drugset / Trial / NCT00101608
Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical research study is to learn if vinflunine can shrink or slow the growth of the cancer or increase survival in patients with transitional cell carcinoma of the urothelium. The safety of this treatment will also be studied.
Timeline
- Start
- 2005-01
- Primary completion
- 2007-04
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vinflunine | Small molecule | 280 mg/m2 | Intravenous |
| Subject | Vinflunine | Small molecule | 320 mg/m2 | Intravenous |